2 assets in Peroxisomal Disease

Therapeutic assets addressing Peroxisomal Disease, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Busulfanum Peroxisomal Disease	Masonic Cancer Center, University of Minnesota	P2	B (57)
Cald Hr-D Peroxisomal Disease	Masonic Cancer Center, University of Minnesota	P2	CCC (53)